Participants 102 132 4
familial adenomatous polyposis
Participants 237 288 4
patients with familial adenomatous polyposis (FAP).
Participants 766 1022 3
EXPERIMENTAL DESIGN Genotyping was performed on seven established FMO3 polymorphisms previously shown to have functional relevance-M66I, P153L, E158K, V257M, E305X, E308G, and R492W-in 21 and 20 FAP patients, who received sulindac and placebo, respectively
Participants 1024 1178 6
RESULTS None of the 41 patients exhibited heterozygous or homozygous M66I and R492W variant alleles, or homozygous P153L, V257M, and E305X variant alleles
